NCT06987227 Effects of Intelligent Parent-child Bonding Intervention on the Physical, Psychological and Social Health of Parents of Premature Infants During Hospitalization and Return Home
| NCT ID | NCT06987227 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Defense Medical Center, Taiwan |
| Condition | Parents of Premature Infants |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2025-05-25 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2025-05-25 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study purpose is to construct and validate the effects of "intelligent parent-child bonding intervention" on the physical, psychological and social health of parents of premature infants.
Eligibility Criteria
Inclusion Criteria: 1. Parents of premature infants born less than 37 weeks of age; 2. Parents of premature infants aged 20 or above and able to communicate in Mandarin and Taiwanese; 3. Parents of premature infants agree to participate in this study and sign the research consent form; 4. The child is currently in the Pediatric and Neonatal Intensive Care Center Exclusion Criteria: 1. The premature baby has congenital abnormalities or is in critical condition and cannot survive; 2. The parents cannot use mobile phones or other Internet devices; 3. The parents have a history of mental illness, intellectual disability or substance abuse.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06987227 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Parents of Premature Infants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06987227 currently recruiting?
Yes, NCT06987227 is actively recruiting participants. Contact the research team at shinnylan@gmail.com for enrollment information.
Where is the NCT06987227 trial being conducted?
This trial is being conducted at Teipei, Taiwan.
Who is sponsoring the NCT06987227 clinical trial?
NCT06987227 is sponsored by National Defense Medical Center, Taiwan. The trial plans to enroll 360 participants.